We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Magnetic Platform Investigates Human Brain Activity

By HospiMedica International staff writers
Posted on 21 Dec 2010
An updated magnetoencephalography (MEG) system addresses requirements that are critical for robust functional mapping studies, particularly in patients with epilepsy. More...


The Elekta Neuromag TRIUX system is designed to operate in virtually any clinical environment due to a dynamic range that has been increased three-fold, in addition to built-in active shielding, which protects the ultrasensitive sensor array. These improvements make the system suitable for placement in busy hospitals and research centers. The system also provides several features designed to simplify day-to-day use, such as a new easy access connector panel and a gantry that allows clinicians and researchers to conduct MEG measurements with the patient in a more comfortable upright position.

Further benefits of the Elekta Neuromag TRIUX system include higher tolerance for magnetic interference, internal active shielding that neutralizes magnetic interference without additional weight or size, new user interface features, and patient comfort enhancements. The Elekta Neuromag TRIUX system is a product of Elekta (Stockholm, Sweden).

"In many clinical research studies, MEG has shown value in the detection of epileptic activity for presurgical evaluation,” said Stephen Otto, chairman of Neuromag Business at Elekta. "MEG provides a noninvasive method to accurately pinpoint the origin of seizure activity by measuring spikes between seizures. It is well tolerated by patients and has been shown to be more sensitive than the functional imaging modalities of PET and SPECT.”

MEG was initially used for fundamental brain research, but an increasing number of hospitals are using the technology for variety of applications, including epilepsy studies. Current studies indicate that up to 25% or more of patients with epilepsy are refractory to all forms of medical therapy; these patients are candidates for surgical treatment in an attempt to achieve better seizure control, while minimizing functional impairment caused by the operation. MEG is used to locate the exact regions of the brain responsible for various functions, and to determine the best surgical route to keep these functions intact.

Related Links:

Elekta


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.